Sci Rep:研究表明lncRNAs或可有助于肌炎的治疗

2017-09-04 MedSci MedSci原创

肌炎的特征是肌肉发炎和无力。虽然一般认为肌炎是由全身自身免疫反应所引发的,但是越来越多的证据表明,肌肉的内在变化也可能参与了肌炎的发病机制。长链非编码RNAs(lncRNAs)是一个新的家庭基因,参与调节基因的转录和翻译。为了确定lncRNAs的潜在作用,研究人员们采用新一代测序以探究肌炎及抗JO1相关肌炎(Jo-1)组织中转录组的表达差异。结果显示,Jo-1和IBM患者肌肉组织中分别有1287个

肌炎的特征是肌肉发炎和无力。虽然一般认为肌炎是由全身自身免疫反应所引发的,但是越来越多的证据表明,肌肉的内在变化也可能参与了肌炎的发病机制。长链非编码RNAs(lncRNAs)是一个新的家庭基因,参与调节基因的转录和翻译。

为了确定lncRNAs的潜在作用,研究人员们采用新一代测序以探究肌炎及抗JO1相关肌炎(Jo-1)组织中转录组的表达差异。结果显示,Jo-1和IBM患者肌肉组织中分别有1287个mRNAs和1068 mRNAs表达差异。通路分析表明,Jo-1和IBM最典型的通路均存在氧化磷酸化和线粒体功能障碍。

研究人员在肌肉活检组织中确定了731个已知和325个未知的新的lncRNAs。与对照组相比,IBM和Jo-1肌炎组织中分别有55个和46个lncRNAs表达存在差异。其中,16个lncRNAs在IBM和Jo-1肌炎组织中均差异表达,包括H19、lncmyod和MALAT1表达上调。

鉴于已知这些lncRNAs参与了调节肌细胞的增殖和分化,研究人员推测lncRNA或可有助于改变Jo-1和IBM肌炎的表型。

原始出处:

Philip D. Hamann, Benoit T. Roux, et al., Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis. Sci Rep. 2017; 7: 8024. Published online 2017 Aug 14. doi: 10.1038/s41598-017-08603-9.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2005638, encodeId=9af820056381f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Aug 01 00:26:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935534, encodeId=afc419355348c, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Sep 26 00:26:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005431, encodeId=0868200543175, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Mar 24 09:26:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301862, encodeId=8f311301862ae, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Sep 06 12:26:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240597, encodeId=a6b424059eb3, content=学习啦!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Sep 05 06:08:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240501, encodeId=808124050162, content=肌炎和肌病, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/208d170d6afc2977ff569bbd0fe70ce1.jpg, createdBy=6e811377745, createdName=qinxyang, createdTime=Mon Sep 04 22:28:47 CST 2017, time=2017-09-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2005638, encodeId=9af820056381f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Aug 01 00:26:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935534, encodeId=afc419355348c, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Sep 26 00:26:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005431, encodeId=0868200543175, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Mar 24 09:26:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301862, encodeId=8f311301862ae, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Sep 06 12:26:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240597, encodeId=a6b424059eb3, content=学习啦!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Sep 05 06:08:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240501, encodeId=808124050162, content=肌炎和肌病, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/208d170d6afc2977ff569bbd0fe70ce1.jpg, createdBy=6e811377745, createdName=qinxyang, createdTime=Mon Sep 04 22:28:47 CST 2017, time=2017-09-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2005638, encodeId=9af820056381f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Aug 01 00:26:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935534, encodeId=afc419355348c, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Sep 26 00:26:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005431, encodeId=0868200543175, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Mar 24 09:26:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301862, encodeId=8f311301862ae, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Sep 06 12:26:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240597, encodeId=a6b424059eb3, content=学习啦!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Sep 05 06:08:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240501, encodeId=808124050162, content=肌炎和肌病, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/208d170d6afc2977ff569bbd0fe70ce1.jpg, createdBy=6e811377745, createdName=qinxyang, createdTime=Mon Sep 04 22:28:47 CST 2017, time=2017-09-04, status=1, ipAttribution=)]
    2018-03-24 dzx0922889
  4. [GetPortalCommentsPageByObjectIdResponse(id=2005638, encodeId=9af820056381f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Aug 01 00:26:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935534, encodeId=afc419355348c, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Sep 26 00:26:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005431, encodeId=0868200543175, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Mar 24 09:26:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301862, encodeId=8f311301862ae, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Sep 06 12:26:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240597, encodeId=a6b424059eb3, content=学习啦!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Sep 05 06:08:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240501, encodeId=808124050162, content=肌炎和肌病, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/208d170d6afc2977ff569bbd0fe70ce1.jpg, createdBy=6e811377745, createdName=qinxyang, createdTime=Mon Sep 04 22:28:47 CST 2017, time=2017-09-04, status=1, ipAttribution=)]
    2017-09-06 xzw113
  5. [GetPortalCommentsPageByObjectIdResponse(id=2005638, encodeId=9af820056381f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Aug 01 00:26:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935534, encodeId=afc419355348c, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Sep 26 00:26:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005431, encodeId=0868200543175, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Mar 24 09:26:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301862, encodeId=8f311301862ae, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Sep 06 12:26:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240597, encodeId=a6b424059eb3, content=学习啦!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Sep 05 06:08:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240501, encodeId=808124050162, content=肌炎和肌病, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/208d170d6afc2977ff569bbd0fe70ce1.jpg, createdBy=6e811377745, createdName=qinxyang, createdTime=Mon Sep 04 22:28:47 CST 2017, time=2017-09-04, status=1, ipAttribution=)]
    2017-09-05 tanxingdoctor

    学习啦!谢谢分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2005638, encodeId=9af820056381f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Aug 01 00:26:00 CST 2018, time=2018-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935534, encodeId=afc419355348c, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Sep 26 00:26:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005431, encodeId=0868200543175, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Mar 24 09:26:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301862, encodeId=8f311301862ae, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Wed Sep 06 12:26:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240597, encodeId=a6b424059eb3, content=学习啦!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Sep 05 06:08:00 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240501, encodeId=808124050162, content=肌炎和肌病, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/208d170d6afc2977ff569bbd0fe70ce1.jpg, createdBy=6e811377745, createdName=qinxyang, createdTime=Mon Sep 04 22:28:47 CST 2017, time=2017-09-04, status=1, ipAttribution=)]
    2017-09-04 qinxyang

    肌炎和肌病

    0

相关资讯

Onco Targets Ther:研究揭示与乳头状肾细胞癌预后相关的分子机制

乳头状肾细胞癌(PRCC)是肾细胞癌的第二个常见的亚型,其治疗和预后缺乏有效的治疗靶点和分子标志物。越来越多的研究关注长链非编码RNAs(lncRNAs)——可以作为竞争性内源性RNA(ceRNA)来竞争microRNAs(miRNAs),在人类肿瘤发生的中的作用。因此,为阐明lncRNA在PRCC中介导ceRNA网络的作用,研究人员全面整合了来自The Cancer Genome Atlas数据

Sci Rep:新的研究揭示脂肪细胞分化的分子机制

脂肪细胞在调节全身能量平衡中的起着重要作用,且与肥胖有着密切的关联。既往许多研究都强调,microRNA在脂肪细胞分化过程中的相关性,但是关于长非编码RNAs(lncRNAs)在脂肪细胞分化过程中的作用仍是未知。本研究中,研究人员确定了lncRNA MIR31HG与脂肪细胞的相关性。体外和体内研究结果表明,敲除MIR31HG可抑制脂肪细胞的分化,而过表达MIR31HG可促进脂肪细胞的分化。此外,抑

Nature:“长的非编码RNAs”在去势抵抗性前列腺癌中上调

几个“长的非编码RNAs”(lncRNAs) 已知在前列腺癌中过度表达。Michael Rosenfeld及同事研究了这些“长的非编码RNAs”中的两个的机制功能和生物功能,它们分别是PRNCR1 和 PCGEM1。二者都被发现依赖于特定的翻译后修饰与雄性激素受体(AR)发生相互作用,增强与AR结合在一起的增强子向目标基因启动子的成环作用(looping),导致基因表达增强。它们还增强前列腺癌细胞